What is the difference between Tiny Health and GI Map stool tests?

Stool tests have been gaining popularity in recent years due to the importance of gut health and the gut-skin connection. In the baby and childhood eczema community, you’ll often hear about two different poop tests: Tiny Health and GI Map.

So, what is the difference between the two and which stool test is best for your eczema baby? Both promise answers. Both analyze your baby’s poop. Both cost hundreds of dollars.

The differences are the technology used, measurement of different things, the analysis, its purpose, and cost.

Understanding the Two Tests: The Basics

GI Map (GI Microbial Assay Plus)

What it is: A comprehensive stool test that utilizes qPCR technology to detect parasites, bacteria, fungi, and more, allowing practitioners to create personalized treatment protocols to address gut dysfunction.

Who makes it: Diagnostic Solutions Laboratory

Primary focus: Detecting specific pathogens, measuring inflammation markers, and assessing digestive function

Technology used: Quantitative PCR (qPCR)

Designed for: All ages, including adults and children, typically ordered through functional medicine practitioners

Tiny Health

What it is: The most complete gut microbiome test for babies and toddlers, designed for ages 0-3, using shotgun metagenomic sequencing.

Who makes it: Tiny Health (a company specifically focused on infant and child microbiome health)

Primary focus: Comprehensive microbiome mapping, diversity assessment, beneficial bacteria levels

Technology used: Shotgun metagenomic sequencing (deep sequencing)

Designed for: Specifically babies, toddlers, and children (though they have adult tests too)

The Critical Difference: PCR vs. Shotgun Sequencing

This is the most important distinction between these tests, and understanding it will help you make an informed choice.

What GI Map’s PCR Technology Does

The GI-MAP uses stool testing to measure the amount of harmful and beneficial bacteria in the gut. It can also determine the different types and quantities of other microorganisms like fungi, viruses, and parasites.

PCR (Polymerase Chain Reaction) technology works by:

Looking for specific, predetermined organisms
Testing only for microbes that are programmed into the test
Being excellent at detecting known pathogens in very low amounts
Providing quantitative data (how much of each targeted organism)

The limitation: PCR methods don’t provide a complete picture of the microbiome. Their focus on specific microbes means they can miss organisms not included in their panel.

What Tiny Health’s Shotgun Sequencing Does

Shotgun metagenomic sequencing reads all the DNA in your sample, without targeting specific organisms first. It provides:

A comprehensive view of your entire microbiome
Detection of organisms not predetermined by the test designers
Species-level identification
Functional gene analysis (what your microbes are actually doing)

The advantage: PCR technology tests for a limited number of microbes in the gut… it is not able to give you a full picture of your microbiome community.

Shotgun sequencing can discover unexpected findings because it’s not limited to a predetermined list.

What the Research Says About These Methods

Studies comparing these methodologies reveal important insights:

Validity and accuracy studies show superior performance compared to other platforms when using whole genome sequencing versus PCR. While PCR can be helpful for known pathogens, mutations will not be detected. PCR can also be limited in the ability to detect every organism.

For infant microbiomes specifically: Decreasing shotgun-metagenomic sequencing depth in children less than 30 months can adequately characterize the infant gut microbiome, showing this technology is validated for babies.

What Each Test Actually Measures

GI Map Measures:

Bacterial Pathogens:

H. pylori
C. difficile
Various pathogenic E. coli strains
Salmonella, Shigella, Campylobacter, etc.

Commensal/Beneficial Bacteria:

Limited panel of beneficial species
Some Lactobacillus and Bifidobacterium species
Several other “beneficial” organisms

Parasites and Protozoa:

Giardia, Cryptosporidium, Blastocystis, etc.

Fungi/Yeast:

Candida species
Other fungal organisms

Viruses:

Some viral targets

Digestive Function Markers:

Pancreatic elastase (enzyme production)
Steatocrit (fat absorption)

Inflammation Markers:

Calprotectin (intestinal inflammation)
Lactoferrin
Secretory IgA (immune function)

The GI Map strength: Excellent for detecting specific pathogens, parasites, and measuring inflammation. Great for identifying acute infections or specific problems.

Tiny Health Measures:

Comprehensive Microbiome Composition:

All bacteria present (not just predetermined ones)
All fungi and other organisms
Species-level identification

Diversity Metrics:

Alpha diversity (how diverse is the microbiome)
Beta diversity (how it compares to healthy reference ranges)

Beneficial Bacteria:

Extensive Bifidobacterium species analysis
Multiple Lactobacillus strains
Other beneficial species

Potential Pathogens:

Opportunistic organisms
Dysbiotic patterns

Functional Analysis:

What genes are present
What metabolic functions the microbiome can perform

Age-Specific References:

Comparison to healthy babies/toddlers of the same age
Developmental microbiome tracking

The Tiny Health strength: Comprehensive microbiome overview, excellent for understanding overall gut balance, diversity, and developmental trajectory. Specifically designed with infant/toddler reference ranges.

For Eczema Specifically: Which Test Tells You More?

This is what you really want to know. Let’s be practical.

What GI Map Can Tell You About Eczema:

Strengths:

Whether there’s intestinal inflammation (calprotectin)
If specific pathogens might be contributing
Candida overgrowth (if that’s suspected)
Pancreatic enzyme function
Immune function markers (secretory IgA)

Limitations:

Limited beneficial bacteria panel
Doesn’t show overall microbiome diversity
May miss important beneficial species not in their panel
Not specifically designed for infant microbiomes

What Tiny Health Can Tell You About Eczema:

Strengths:

Overall microbiome diversity (lower diversity is linked to eczema)
Specific Bifidobacterium species that research links to eczema protection
Comprehensive beneficial bacteria assessment
Age-appropriate reference ranges (babies have different “healthy” ranges than adults)
Patterns of dysbiosis associated with allergic conditions
Longitudinal tracking (see how interventions change the microbiome)

Limitations:

Less focused on acute pathogen detection
Doesn’t measure inflammation markers like calprotectin
May provide “too much” information without clear clinical pathways

What the Research Says Matters for Infant Eczema

Let’s connect this back to what we know about eczema and the infant gut:

The Diversity Connection

Remember from our earlier discussions: Low intestinal microbial diversity during the first month of life was associated with subsequent atopic eczema.

Which test measures this better? Tiny Health, hands down. Shotgun sequencing provides comprehensive diversity metrics that PCR-based tests cannot match.

The Bifidobacterium Specificity

Research has identified that specific Bifidobacterium species (not just “Bifidobacterium” as a group) are protective against eczema.

Which test identifies species better? Tiny Health’s shotgun sequencing provides species-level identification for all organisms, while GI Map’s PCR panel tests only for predetermined species.

The Inflammation Question

If you suspect your baby has significant gut inflammation or potential infection, measuring calprotectin and other inflammatory markers is valuable.

Which test measures inflammation? GI Map includes these markers; Tiny Health does not.

The Practical Considerations

Cost:

GI Map: Typically $350-400+ USD
Tiny Health: Typically $179-299 USD depending on package
Both are out-of-pocket (usually not covered by insurance)

Ordering Process:

GI Map: Usually requires ordering through a practitioner
Tiny Health: Direct-to-consumer (you can order yourself)

Sample Collection:

GI Map: Standard stool sample collection
Tiny Health: Small sample collection (easier with babies/toddlers)

Interpretation:

GI Map: Requires practitioner interpretation (functional medicine doctor, naturopath)
Tiny Health: Comes with detailed interpretation report designed for parents, plus optional practitioner consultation

Follow-Up Testing:

GI Map: Expensive to retest
Tiny Health: More affordable for longitudinal tracking

Which Test Is “Best” for Your Baby?

The honest answer: It depends on what you’re looking for.

Choose GI Map If:

You suspect a specific pathogen or parasite
Your baby has had severe digestive symptoms (chronic diarrhea, blood in stool)
You want to measure inflammation markers
Your functional medicine practitioner specifically recommends it
You’re working with someone who knows how to interpret and treat based on GI Map results

Choose Tiny Health If:

You want to understand overall microbiome health and diversity
You’re focused on the gut-eczema connection specifically
You want age-appropriate reference ranges for babies/toddlers
You want to track changes over time affordably
You want comprehensive beneficial bacteria analysis
You’re interested in a more complete microbiome picture

Consider Both If:

Your baby has both severe eczema AND significant digestive symptoms
You have the financial resources and want both perspectives
You’re working with a practitioner who can synthesize information from both

What the Research Says Is Most Important for Infant Gut Health

When we look at what actually matters for infant gut health and eczema, the research points to:

Microbiome diversity: Lower diversity = higher eczema risk
Specific beneficial bacteria: Especially Bifidobacterium species
Absence of dysbiosis: Balanced microbial community
Age-appropriate composition: What’s healthy changes month by month in infants

Amplicon sequencing provides more accurate microbiome information in healthy children compared to culturing, and by extension, comprehensive sequencing provides more complete information than targeted PCR.

For understanding infant microbiome development and its connection to eczema, shotgun metagenomic sequencing (Tiny Health’s approach) aligns better with current research methodologies.

The Limitations of Both Tests

Let’s be honest about what stool testing—any stool testing—can and cannot do:

What Stool Tests Can Do:

Show you what organisms are present
Identify potential imbalances
Track changes over time
Guide targeted interventions

What Stool Tests Cannot Do:

Tell you definitively what’s causing eczema
Provide a “cure” roadmap
Replace clinical judgment
Guarantee that interventions will work

Both GI Map and Tiny Health are tools for gathering information—valuable tools, but just tools. They need to be interpreted within the context of your baby’s overall health picture.

A Practical Approach

If you’re considering stool testing for your baby’s eczema, here’s a thoughtful framework:

Start With These Questions:

Does my baby have signs of acute infection or parasites? (If yes, lean toward GI Map)
Am I primarily interested in the gut-eczema connection? (If yes, lean toward Tiny Health)
Am I working with a practitioner who specializes in one test? (Use what they’re trained in)
Do I want to track changes affordably over time? (If yes, lean toward Tiny Health)
Is my budget limited? (Tiny Health is typically more affordable)

Consider Your Goals:

Short-term: Identify acute problems → GI Map may be better
Long-term: Track microbiome development and optimize → Tiny Health may be better
Comprehensive: Both tests provide different valuable information

Work With Knowledge:

Whichever test you choose, work with someone who:

Understands infant microbiome research
Can interpret the specific test you’re using
Won’t make grandiose claims about “fixing” everything
Considers test results alongside clinical presentation
Has experience with pediatric gut health

The Bottom Line

For most mothers trying to understand their baby’s gut health in relation to eczema, Tiny Health is likely the better choice because:

It provides comprehensive microbiome data including diversity metrics
It has age-specific reference ranges for infants and toddlers
It aligns with current microbiome research methodologies
It’s more affordable for tracking changes over time
It’s specifically designed for the pediatric population

However, GI Map has its place when:

Specific pathogen detection is needed
Inflammation markers are important to measure
Your practitioner specializes in interpreting it
Acute digestive issues are present

Ideally, the perfect assessment would combine:

Comprehensive microbiome sequencing (Tiny Health’s strength)
Inflammation markers (GI Map’s strength)
Clinical evaluation by knowledgeable practitioner
Longitudinal tracking over time

Moving Forward Wisely

Remember: stool testing is one piece of information. It’s valuable, but it’s not magic.

Whether you choose GI Map, Tiny Health, both, or neither, the most important factors are:

Working with someone who understands infant gut health
Implementing evidence-based interventions
Being patient with the process
Not bankrupting yourself chasing perfect test results
Remembering that your baby’s eczema is multifactorial

Stool testing can guide you, but it doesn’t have all the answers. Use it as a tool alongside clinical wisdom, research-based interventions, and your own observations of your child.

Key Research Sources

Diagnostic Solutions Laboratory: GI-MAP test methodology and markers
Tiny Health: Shotgun metagenomic sequencing technology
Paloma Health: Comprehensive GI-MAP interpretation guide
Tiny Health Blog: PCR vs. shotgun sequencing comparison
Frontiers in Microbiology: Comparative analysis of sequencing methods in pediatric gut microbiomes
PMC Research: Whole genome sequencing superior performance vs. PCR
Communications Biology: Amplicon sequencing accuracy in healthy children
Maternal Health, Neonatology and Perinatology: Methods for exploring infant microbiome

Remember: Stool testing should be done in consultation with healthcare providers familiar with pediatric gut health and microbiome interpretation. This is not health care advice.